hemopyrrollactamuria and glutathione depletion

hemopyrrollactamuria and glutathione depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Glutathione depletion based Pt(IV) hybrid

Name: hemopyrrollactamuria and glutathione depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Glutathione depletion based Pt(IV) hybrid
Brand: mlbdaktechniek.nl
SKU: 51119509349
Price: 27.09 USD
Availability: InStock
Rating: 4.6606000000000005 (26 reviews)

Glutathione depletion based Pt(IV) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A one stone three birds strategy ScienceDirect hemopyrrollactamuria and glutathione depletion Application of in cancer therapy: Enhanced ROS based therapy, ferroptosis, chemotherapy Current Insights into Glutathione Depletion in Adult Septic Patients Glutathione depletion induces oxidative injury and apoptosis via TRPM2 channel activation in renal collecting duct cells ScienceDirect Glutathione Depletion Disrupts Redox Homeostasis in an Anoxia Tolerant Invertebrate

SKU: 51119509349 · From mlbdaktechniek.nl

4.7

USD27.09 USD62.09

Pay in 4 interest-free payments of $6.77 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

Ralat LA, Colman RF

Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Loreal O

Induction of significant anticancer effects by YK1 in KRAS G13D CRC tumors G13D To further evaluate the efficacy of YK1, we assessed its in vivo effects using a xenograft mouse model with the SW48 G13D cell line